CLOT Conversations

Thrombotic & Bleeding Outcomes following AC interruption in NVAF and Ca with Dr Joseph Shaw & Dr Tzu-Fei Wang

Dr Jameel Abdulrehman & David Airdrie Season 1 Episode 20

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 25:45

Send us Fan Mail

Don't miss our latest podcast interview with Dr Joseph Shaw and Dr Tzu-Fei Wang who discuss insights from their single-center retrospective cohort study, which included 264 patients with nonvalvular AF and Cancer undergoing 302 periprocedural interruptions. Learn about the primary endpoints, which were the 30-day risks of arterial thromboembolism and major bleeding, and the results that showed relatively low risk for these complications when patients were managed according to commonly applied perioperative management recommendations. Tune in now to gain valuable knowledge on this important topic.

Aziz, Joseph, et al. "Thrombotic and Bleeding Outcomes Following the Perioperative Interruption of Anticoagulation Among Patients with Non-Valvular Atrial Fibrillation and Active Cancer." Journal of Thrombosis and Haemostasis (2022).

Follow us on Twitter
Dr Shaw: @JRand083
Dr Wang: @TzufeiWang
@thrombosiscanada.ca

www.thrombosiscanada.ca

Support the show

https://thrombosiscanada.ca

Register today for our upcoming conference on November 7, 2026 in Montreal at https://thrombosiscanada.ca/2026Conference

Take a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada